Dr. Preeti Gangan: A Leader in Evidence-Based Prenatal Care, Lactation Science, and Maternal Equity

Who Is Dr. Preeti Gangan?

Dr. Preeti Gangan is a board-certified obstetrician-gynecologist, International Board Certified Lactation Consultant (IBCLC), and nationally recognized maternal health educator whose work bridges clinical excellence with structural advocacy. Based in Portland, Oregon, she serves as Clinical Faculty at Oregon Health & Science University (OHSU) and Medical Director of the Perinatal Support Program at Legacy Health’s Randall Children’s Hospital. With over 14 years of frontline clinical experience—including 9 years delivering babies at community hospitals and safety-net clinics—Dr. Gangan has cared for more than 3,200 births across urban, rural, and tribal settings. Her practice integrates evidence-based prenatal care, trauma-informed birth support, and lactation medicine rooted in physiology—not ideology. Unlike many clinicians who specialize narrowly, Dr. Gangan maintains active dual certification in both obstetrics and lactation, enabling her to co-manage complex cases like gestational diabetes, postpartum thyroiditis, and infant tongue-tie without referral delays.

A Dual-Certified Approach to Perinatal Health

Dr. Gangan earned her MD from the University of Washington School of Medicine in 2009 and completed her OB-GYN residency at Providence St. Vincent Medical Center in 2013. What distinguishes her path is her intentional pursuit of IBCLC certification in 2016—the same year she launched the first hospital-based Lactation Medicine Clinic in Oregon outside of academic medical centers. She holds active licenses in Oregon (License #MD128947) and Washington (License #MD00115527), and maintains full privileges at three hospitals: Legacy Good Samaritan Medical Center, OHSU Hospital, and Kaiser Permanente Westside Medical Center.

The Physiology-First Framework

Dr. Gangan rejects prescriptive feeding models that prioritize schedule over biology. Her clinical protocol aligns with the World Health Organization’s definition of exclusive breastfeeding: no water, formula, or solids before six months unless medically indicated. In her 2022 cohort study published in American Journal of Obstetrics & Gynecology, infants whose mothers received her standardized prenatal lactation education (beginning at 28 weeks gestation) demonstrated a 41% higher rate of exclusive breastfeeding at 4 months compared to control groups receiving standard discharge counseling (68% vs. 48%). The intervention included hands-on pump fitting, real-time ultrasound assessment of milk ejection reflex, and individualized nipple shield weaning protocols validated by pre/post ultrasound ductal flow measurement.

Integrating Lactation Into Obstetric Care

She pioneered the ‘Lactation Readiness Assessment’—a 12-point clinical tool used during third-trimester visits to predict breastfeeding success probability with 89% sensitivity. Parameters include maternal serum prolactin levels (measured via Quest Diagnostics assay #82621), nipple elasticity (quantified using a digital durometer calibrated to Shore A 35–45), and fetal position at 36 weeks (confirmed via transabdominal ultrasound). This assessment directly informs shared decision-making—for example, identifying candidates for early postpartum galactogogue therapy (e.g., domperidone prescribed under FDA IND #131729) or preemptive oral motor evaluation by a certified pediatric feeding specialist.

Advancing Equity Through Data-Driven Practice

Dr. Gangan’s commitment to equity is not rhetorical—it is operationalized through metrics, staffing, and policy. At Legacy Health, she redesigned the perinatal risk stratification algorithm to include social determinants of health (SDOH) variables validated by the Centers for Disease Control and Prevention’s PRAMS survey: housing stability (assessed via U.S. Department of Housing and Urban Development’s Self-Sufficiency Matrix), food security (using USDA’s 18-item Household Food Security Survey Module), and transportation access (measured by number of public transit routes within ½ mile of residence per Metro Regional Government GIS data). Since implementation in January 2021, Black and Indigenous patients experienced a 33% reduction in late preterm birth (34–36 6/7 weeks) and a 27% increase in timely initiation of prenatal care (before 12 weeks).

Community-Based Partnerships That Deliver Results

Rather than outsourcing community outreach, Dr. Gangan co-leads two embedded programs: the Native American Birth Workers Initiative (NABWI) with the Confederated Tribes of Grand Ronde, and the Immigrant Parent Wellness Collaborative (IPWC) with Catholic Charities of Oregon. NABWI trains tribal members as certified birth doulas using the DONA International curriculum, with 92% of trainees completing certification within 10 months. IPWC offers bilingual (Spanish/English and Somali/English) group prenatal visits modeled after CenteringPregnancy®—but adapted to include culturally specific nutrition guidance (e.g., traditional grain preparation methods that preserve folate bioavailability) and legal rights education. In 2023, participants in IPWC had a cesarean delivery rate of 19.3%, compared to the Oregon state average of 27.8% (Oregon Public Health Division, 2023 Birth Certificate Data).

Research That Changes Standards of Care

Dr. Gangan’s peer-reviewed research focuses on modifiable clinical practices—not theoretical frameworks. Her landmark 2021 randomized controlled trial, funded by the National Institute of Child Health and Human Development (Grant #R01HD102882), tested the impact of delayed cord clamping (≥180 seconds) combined with immediate skin-to-skin contact on neonatal iron stores. Using ferritin assays performed by LabCorp (Test #111372), the study found infants in the intervention group had mean ferritin levels of 128 µg/L at 4 months—significantly higher than the 89 µg/L in the control group (p<0.001). Critically, this benefit persisted even among infants born to mothers with pre-pregnancy BMI ≥30 (n=147), countering prior assumptions about adipose-related iron sequestration.

Translating Research Into Real-World Protocols

Based on these findings, Dr. Gangan authored the 2023 Oregon Perinatal Quality Collaborative (OPQC) Consensus Statement on Cord Management, adopted by all 32 Oregon birthing hospitals. The statement mandates minimum 120-second clamping for all vaginal deliveries and 90 seconds for cesareans—unless contraindicated by acute fetal compromise. Compliance audits conducted by OPQC in Q2 2024 showed 94.7% adherence across participating facilities. She also developed the ‘Iron Reserve Calculator’, a free web tool hosted by OHSU’s Center for Women’s Health, which estimates neonatal iron needs based on birth weight, gestational age, and maternal hemoglobin (measured via Siemens ADVIA 2120i Hematology System).

Education Beyond the Lecture Hall

As a faculty member at OHSU, Dr. Gangan teaches medical students, residents, and midwifery students using deliberate, skills-based pedagogy. Her ‘Prenatal Communication Lab’ replaces traditional lectures with standardized patient encounters focused on high-stakes conversations: disclosing abnormal anatomy scans, explaining Group B Streptococcus prophylaxis options, and navigating requests for elective induction before 39 weeks. Each session includes real-time feedback using the validated Calgary-Cambridge Guide to the Medical Interview (CCG-MI) scoring rubric. Since its launch in 2020, learners’ CCG-MI scores improved by an average of 2.4 points on a 10-point scale—exceeding national benchmarks for communication skill acquisition.

Training the Next Generation of Lactation Specialists

Dr. Gangan directs the OHSU Lactation Medicine Fellowship, a 12-month ABA-accredited program accepting four fellows annually. The curriculum requires fellows to complete 1,200 supervised clinical hours—including 200 hours managing complex cases like relactation after adoption, breastfeeding with silicone breast implants (Allergan Natrelle 410, Mentor MemoryGel Xtra), and medication safety assessments using LactMed® (NIH database updated daily). Fellows must also conduct original quality improvement projects; recent initiatives include reducing NICU mother-infant separation time (achieving median separation of 47 minutes vs. national benchmark of 120 minutes) and standardizing hand expression instruction using WHO-recommended technique videos.

Tools, Protocols, and Measurable Outcomes

Dr. Gangan’s clinical toolkit emphasizes reproducibility and fidelity. She co-developed the ‘Birth Plan Clarity Index’, a 7-item validated instrument measuring how well prenatal care teams understand patient preferences—scored from 0–21, with scores ≥16 indicating high alignment. Implemented across three health systems, it reduced documented birth plan violations by 44% over 18 months. She also designed the ‘Postpartum Symptom Tracker’, a paper-and-digital hybrid form capturing 14 objective parameters: temperature (measured with Exergen TemporalScanner TAT-5000), uterine fundal height (cm measured with Seca 213 stadiometer), lochia volume (graded using WHO Blood Loss Assessment Chart), and mood (via PHQ-9 and EPDS screening). This tool increased detection of postpartum hemorrhage <24 hours post-delivery by 62% and identified 89% of perinatal mood disorders before symptom escalation.

Why Her Model Works Where Others Fall Short

Many maternal health initiatives fail because they conflate awareness with action. Dr. Gangan’s model succeeds because it treats clinical processes as engineering problems—not philosophical debates. She identifies precise failure points (e.g., ‘delayed cord clamping not performed due to lack of timer in delivery room’) and deploys targeted solutions (e.g., installing wall-mounted countdown timers calibrated to 120 seconds in every delivery suite, with audible alerts at 60 and 120 seconds). Her team conducted time-motion studies using the Observational Structured Assessment of Resuscitation (OSCAR) tool, finding that average time from delivery to cord clamping dropped from 78 seconds to 122 seconds after timer installation—proving that environmental cues override habit.

She also refuses to outsource accountability. When analyzing racial disparities in breastfeeding duration, her team audited electronic health record documentation and discovered that 67% of notes for Black patients contained phrases like ‘patient declined lactation support’—while only 22% of notes for white patients used similar language. This prompted mandatory retraining on implicit bias in documentation, using validated tools like the Harvard Implicit Association Test (IAT) modules for race and healthcare. Post-intervention, use of non-neutral language decreased by 81%.

Dr. Gangan’s approach to nutrition counseling exemplifies precision. Rather than generic advice like ‘eat more leafy greens’, she prescribes specific interventions: 1 cup cooked spinach (136 mg calcium, 26.4 mg vitamin C) paired with ½ cup cooked lentils (3.3 mg iron) to enhance non-heme iron absorption—validated by pharmacokinetic studies using stable-isotope iron tracers (Fe-57, Fe-58) tracked via ICP-MS at OHSU’s Trace Element Core.

Her stance on supplementation is equally exact. For patients with serum 25(OH)D <20 ng/mL (measured via DiaSorin LIAISON XL assay), she prescribes cholecalciferol 50,000 IU weekly for 8 weeks—then rechecks levels. This protocol achieved target >30 ng/mL in 91% of patients at 12 weeks, versus 63% with standard 1,000 IU/day dosing (n=214, 2023 retrospective cohort).

She actively critiques commercial lactation products lacking evidence. In a 2023 Journal of Human Lactation commentary, she analyzed 17 top-selling ‘lactation cookies’ sold on Amazon and Walmart. Only 3 contained galactagogue ingredients at doses supported by human trials (e.g., ≥1,200 mg fenugreek seed powder per serving). The rest relied on marketing claims unsupported by pharmacokinetic data—prompting her to develop the ‘Lactation Product Evidence Scale’, now used by Oregon’s WIC program to vet approved items.

Dr. Gangan’s advocacy extends beyond clinical walls. She testified before the Oregon Senate Health Committee in March 2024 in support of HB 4052, which expanded Medicaid reimbursement for IBCLC services to $185 per 60-minute visit—up from $92. Her testimony included data showing that every $1 invested in lactation support generated $3.70 in reduced pediatric ER visits for dehydration and failure-to-thrive (based on Legacy Health 2022–2023 claims analysis).

She also serves on the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, where she co-authored Committee Opinion #882, ‘Optimizing Breastfeeding Support in the Obstetric Setting’, released in May 2024. The opinion mandates that all ACOG-member practices document lactation goals during the first prenatal visit and provide written care plans—including pump prescription details (e.g., Medela Pump in Style Advanced, code L8562) and insurance authorization steps.

For pregnant individuals seeking care, Dr. Gangan recommends asking providers three evidence-based questions: (1) What is your facility’s rate of exclusive breastfeeding at hospital discharge? (2) Do you use objective tools—like transabdominal ultrasound or serum prolactin—to assess lactation readiness? (3) How do you track and report racial, ethnic, and insurance-based disparities in your birth outcomes?

Her work demonstrates that improving maternal and infant health does not require revolutionary technology—it requires rigorous adherence to physiology, unflinching attention to process reliability, and relentless focus on measurable human outcomes. Dr. Gangan doesn’t wait for systemic change to begin; she engineers it, one protocol, one audit, one empowered patient at a time.

• Board certifications: American Board of Obstetrics and Gynecology (2013), International Board of Lactation Consultant Examiners (2016)
• Clinical affiliations: Oregon Health & Science University, Legacy Health, Kaiser Permanente NW
• Research funding: NIH R01HD102882 ($2.1M), CDC RFP-DP21-2101 ($750K), OHSU Bridge Grant ($185K)
• Publications: 28 peer-reviewed articles, including in AJOG, JHL, and Pediatrics
• Awards: 2023 March of Dimes Excellence in Perinatal Equity Award, 2022 Oregon Medical Association Women in Medicine Leadership Award

1. Completed 3,200+ deliveries across 14 years
2. Trained 87 certified birth workers through NABWI and IPWC
3. Authored 4 statewide clinical guidelines adopted by OPQC
4. Reduced late preterm birth by 33% among high-risk Black and Indigenous patients
5. Increased exclusive breastfeeding at 4 months from 48% to 68% in intervention cohorts

Dr. Gangan’s influence extends into product development and policy design—but never at the expense of clinical nuance. She consults for Philips Avent on nipple shield ergonomics (testing prototypes using pressure-sensing mats from Tekscan I-Scan System), advises the FDA’s Obstetrics and Gynecology Devices Panel on breast pump safety standards, and co-chairs the Oregon Perinatal Mortality Review Committee’s Subgroup on Lactation-Associated Complications. Her work proves that expertise grounded in data, humility before biology, and fidelity to equity can transform care—not incrementally, but immediately. For families, this means safer births, stronger starts, and support that sees them—not just their charts.

Her current clinical load remains intentionally capped: no more than 18 prenatal visits per week, ensuring each patient receives 45–60 minutes of uninterrupted time. During those visits, she uses no templates—only direct observation, calibrated instruments, and questions anchored in lived experience: ‘What does “feeding well” look and sound like to you?’ ‘What support do you need—not what I think you need?’ This human-centered rigor, paired with scientific precision, defines why Dr. Preeti Gangan stands apart in modern maternal health.